The Current Ratio as of September 2024 (TTM) for Marker Therapeutics, Inc. (MRKR) is 5.92

According to Marker Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.92. This represents a change of -3.82% compared to the average of 6.15 of the last 4 quarters.

Marker Therapeutics, Inc. (MRKR) Historical Current Ratio (quarterly & annually)

How has MRKR Current Ratio performed in the past?

The mean historical Current Ratio of Marker Therapeutics, Inc. over the last ten years is 6.84. The current 5.92 Current Ratio has changed 8.55% with respect to the historical average. Over the past ten years (40 quarters), MRKR's Current Ratio was at its highest in in the December 2019 quarter at 22.83. The Current Ratio was at its lowest in in the June 2016 quarter at 0.16.

Marker Therapeutics, Inc. (MRKR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Marker Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Marker Therapeutics, Inc. (MRKR) Average Current Ratio

How has MRKR Current Ratio performed in the past?

The current Current Ratio of Marker Therapeutics, Inc. (MRKR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Marker Therapeutics, Inc. (MRKR) Current Ratio vs. Peers

How is MRKR’s Current Ratio compared to its peers?

Marker Therapeutics, Inc.’s Current Ratio is greater than Lumos Pharma, Inc. (4.23), greater than Exicure, Inc. (0.61), greater than Protagenic Therapeutics, Inc. (2.03), less than PMV Pharmaceuticals, Inc. (19.22), greater than Anebulo Pharmaceuticals, Inc. (5.32), greater than Miromatrix Medical Inc. (3.46), greater than ZIVO Bioscience, Inc. (0.17), greater than Bionomics Limited (3.81), greater than Agenus Inc. (0.37), less than Icosavax, Inc. (18.06), greater than Galera Therapeutics, Inc. (5.63), less than Edgewise Therapeutics, Inc. (30.24), greater than RenovoRx, Inc. (4.39), greater than Tempest Therapeutics, Inc. (2.17), less than Ikena Oncology, Inc. (18.22), greater than Catalyst Biosciences, Inc. (0), less than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than Alector, Inc. (3.52), greater than Aadi Bioscience, Inc. (4.20), less than Keros Therapeutics, Inc. (20.37), less than Aerovate Therapeutics, Inc. (6.51),

Build a custom stock screener for Marker Therapeutics, Inc. (MRKR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marker Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marker Therapeutics, Inc. (MRKR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marker Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.